Some Chemoimmunotherapy Regimens May Reactivate HBV in B-Cell NHL – Clinical Oncology News

Some Chemoimmunotherapy Regimens May Reactivate HBV in B-Cell NHL Clinical Oncology News

Data from two phase 3 studies of patients with B-cell non-Hodgkin lymphoma (NHL) with resolved hepatitis B virus (HBV) infection found that obinutuzumab- or …

…read more

Via:: NHL Headlines

      

Get 20% off hat purchases for ONLY $5! Join our LIDS Club @ lids.com.
%d bloggers like this: